What Makes LifeStance Health Group (LFST) a Strong Momentum Stock: Buy Now?
Does LifeStance Health Group (LFST) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks Investment Research11/6/2026Positive
LFST
Lifestance Health Group IncNASDAQHEALTHCAREMEDICAL CARE FACILITIES
Key Statistics
Market Cap
$5.23B
P/E Ratio
76.50
EPS
$0.18
Beta
1.30
52W High
$15.66
52W Low
$5.98
50-Day MA
$12.59
200-Day MA
$9.46
Dividend Yield
—
Profit Margin
4.29%
Forward P/E
58.48
PEG Ratio
—
About Lifestance Health Group Inc
LifeStance Health Group, Inc., provides outpatient mental health services to children, adolescents, adults and geriatrics. The company is headquartered in Scottsdale, Arizona.
Fundamentals
| Revenue (TTM) | $1.68B |
| Gross Profit (TTM) | $576.67M |
| EBITDA | $161.05M |
| Operating Margin | 7.26% |
| Return on Equity | 4.82% |
| Return on Assets | 3.03% |
| Revenue/Share (TTM) | $4.36 |
| Book Value | $3.92 |
| Price-to-Book | 3.45 |
| Price-to-Sales (TTM) | 3.12 |
| EV/Revenue | 3.366 |
| EV/EBITDA | 40.52 |
| Quarterly Earnings Growth (YoY) | 2021.00% |
| Quarterly Revenue Growth (YoY) | 25.30% |
| Shares Outstanding | $380.15M |
| Float | $288.82M |
| % Insiders | 3.07% |
| % Institutions | 89.01% |
Historical Volatility
HV 10-Day
48.86%
HV 20-Day
43.70%
HV 30-Day
37.83%
HV 60-Day
33.88%
HV Rank
40.9%
Volatility is currently expanding
Analyst Ratings
Consensus ($14.45 target)
2
Strong Buy7
Buy2
HoldLatest News
LifeStance Health Group, Inc. (LFST) Hits Fresh High: Is There Still Room to Run?
LifeStance Health (LFST) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks Investment Research11/6/2026Positive
What LifeStance Health Group (LFST) Said on Its Q3 Earnings Call
LifeStance Health Group NASDAQ: LFST raised its full-year 2026 outlook after reporting 25% third-quarter revenue growth, driven by more patient visits and higher revenue per visit. The mental health care provider also said its planned electronic health record transition could temper revenue growth in 2027.
MarketBeat11/6/2026Positive
LifeStance Health Group (LFST) Tops Q3 Earnings and Revenue Estimates
LifeStance Health Group (LFST) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to break-even earnings per share a year ago.
Zacks Investment Research11/5/2026Positive
LifeStance Reports Strong Third Quarter 2026 Financial Results and Raises Full Year Outlook
SCOTTSDALE, Ariz., Nov. 05, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the third quarter ended September 30, 2026.
GlobeNewsWire11/5/2026Neutral
LifeStance Patients With Treatment-Resistant Depression See Clinically Meaningful Improvement in Symptoms After Esketamine or TMS Treatment, New Data Shows
LifeStance Expands Specialty Services, Increasing Access to Esketamine (Spravato) and Transcranial Magnetic Stimulation (TMS) Across the U.S. SCOTTSDALE, Ariz., Oct. 29, 2026 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of outpatient mental healthcare, is expanding access to two specialty services for treatment-resistant depression – esketamine1 (Spravato) and transcranial magnetic stimulation2 (TMS) – as separate analyses show meaningful reductions in depression symptoms and suicidal ideation among patients receiving each treatment.
PRNewsWire10/29/2026Neutral
LifeStance to Host Third Quarter 2026 Earnings Conference Call on November 5, 2026
SCOTTSDALE, Ariz., Oct. 15, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental healthcare, will issue its third quarter 2026 earnings release before the market opens on Thursday, November 5, 2026.
GlobeNewsWire10/15/2026Neutral
Take the Zacks Approach to Beat the Markets: HF Sinclair, Accenture & FirstCash in Focus
HF Sinclair, Accenture and FirstCash post impressive gains as Zacks research portfolios highlight standout performers amid market uncertainty and shifting investor sentiment.
Zacks Investment Research10/12/2026Positive
LifeStance Health Group, Inc. (LFST) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
LifeStance Health Group, Inc. (LFST) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Seeking Alpha9/15/2026Neutral
Here's Why LifeStance Health Group (LFST) is a Great Momentum Stock to Buy
Does LifeStance Health Group (LFST) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks Investment Research9/10/2026Positive
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on LFST and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 11/7/2026